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Abstract:  Macroautophagy is a catabolic pathway in eukaryotic cells that has recently 
been  shown  to  facilitate  pathogen  detection,  pathogen  restriction  and  pathogen-derived 
antigen presentation to CD4
+ T cells. Due to these protective functions during immune 
responses, several pathogens, including RNA and DNA viruses, have developed strategies 
to inhibit autophagosome generation or maturation. Interestingly, most of the respective 
viral proteins exert these functions via binding to Beclin-1, an essential macroautophagy 
protein  that  constitutes  part  of  the  phosphatidylinositol-3  kinase  complexes  that  mark 
membranes  for  autophagosome  generation  and  facilitate  autophagosome  fusion  with 
lyososomes.  The  viruses  that  inhibit  macroautophagy  by  this  pathway  include 
herpesviruses, HIV and influenza A virus. Inhibition either before or after autophagosome 
formation  seems  to  benefit  their  viral  replication  by  different  mechanisms,  which  are 
discussed here. 
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1. Introduction 
Lysosomes  and  proteasomes  are  the  two  main  catabolic  machineries  in  eukaryotic  cells. 
Endocytosed, but also autophagocytosed material can reach lysosomes, thereby delivering extra- or 
intracellular material for degradation, respectively. At least three pathways of autophagy exist for the 
delivery  of  cytoplasmic  constituents  for  lysosomal  degradation.  These  are  macro-,  micro-  and 
chaperone-mediated autophagy [1]. While micro- and chaperone-mediated autophagy occur directly at 
the lysosomal membrane, macroautophagy can originate at the rough endoplasmic reticulum, Golgi 
apparatus,  outer  nuclear  or  mitochondrial  membrane,  and  the  cell  membrane  [2–10].  During 
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microautophagy a part of the lysosomal membrane invaginates into the lumen of these degradative 
vesicles and thereby delivers cytosolic substrates for lysosomal hydrolysis. In higher eukaryotes this 
seems to occur with the help of the chaperone HSC70 [11]. Chaperone-mediated autophagy, however, 
has been observed in higher eukaryotic cells only after prolonged starvation. Under these conditions, 
substrates  with  a  signal  motif,  a  permutation  of  the  pentamer  KFERQ, get  transported  across  the 
lysosomal  membrane  with  the  help  of  the  lysosome  associated  membrane  protein  (LAMP)  2a, 
cytosolic chaperones and luminal chaperones in the lysosomes. Signal peptide recognition seems to 
occur via the cytosolic chaperone, and therefore similar substrates are selected for microautophagy and 
chaperone mediated autophagy in higher eukaryotic cells [11]. Finally, most steady-state turn-over of 
cytosolic  protein  aggregates  and  organelles  in  lysosomes  of  higher  eukaryotes  seems  to  require 
macroautophagy for delivering these substrates. Macroautophagy is executed through the interaction of 
more  than  30  autophagy  related  gene  (atg)  products,  whose  loss  prevents  yeast  from  surviving 
starvation conditions via this pathway. During this process a double membrane, called a phagophore, 
engulfs substrates, anchoring the inner autophagosomal membrane to the cargo via Atg8/LC3, which is 
covalently attached to phosphatidylethanolamine in the autophagosomal membrane via an ubiquitin-like 
conjugation reaction involving the E1-, E2- and E3-like enzymes Atg7, Atg3 and Atg12-Atg5/Atg16L1 
[12,13]. Atg8/LC3 is either directly bound by a cargo protein, like the outer mitochondrial membrane 
protein NIX for mitophagy [14,15], or by anchor proteins, like p62/sequestosome 1, optineurin, NBR1 
or  NDP52  [16–20],  that  cross-link  Atg8/LC3  with  polyubiquitinated  substrates.  The  completed 
autophagosome  then  fuses  with  late  endosomes  or  directly  with  lysosomes,  whereby  the  inner 
membrane  and  its  cargo  get  degraded  by  lysosomal  hydrolysis.  Autophagosome  generation  and 
degradation  is  regulated  by  class  III  phosphatidylinositol-3-kinase  (PI3K)  complexes  including 
Atg6/Beclin-1. Therefore, viruses often interfere with these complexes via targeting Beclin-1 in order 
to arrest autophagosome formation or maturation. 
2. Beclin-1 Containing Complexes and Their Role in Macroautophagy 
During autophagosome initiation Atg6/Beclin-1 is associated with the PI3K VPS34 and the adaptor 
proteins myristoylated VPS15 for membrane anchoring and Atg14L (Figure 1) [21–23]. This complex 
marks membranes for phagophore formation with PI3P, for example downstream of the starvation 
induced ULK complexes [24]. For incorporation into this complex Atg6/Beclin-1 has to dissociate 
from the anti-apoptotic Bcl-2 and Bcl-xL proteins, which anchor Atg6/Beclin-1 at the endoplasmic 
reticulum membrane. The Beclin-1 interacting protein AMBRA1 disrupts this interaction and thereby 
activates macroautophagy [25]. Vice versa, macroautophagy is compromised by mono-allelic deletion 
of  Beclin-1  in  40–75%  of  ovarian  and  breast  carcinomas  [26,27].  These  factors  influence  the 
generation of autophagosomes. In addition, the maturation, namely fusion of autophagosomes with 
lysosomes, is influenced by Beclin-1 containing VPS34 complexes. Instead of Atg14L, however, these 
contain the UV irradiation resistance-associated gene (UVRAG). This protein enhances autophagosome 
maturation, but again a negative regulator exists in the form of the Rubicon protein, which associates 
with the UVRAG containing Beclin-1 complex and arrests autophagosome maturation [21,22]. Thus, 
higher eukaryotic cells carry sophisticated molecular machineries for the regulation of PI3P deposition Viruses 2011, 3                                       
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at future or formed autophagosomal membranes to react to metabolic needs, but also infections by 
regulating macroautophagy. 
Figure  1.  Atg6/Beclin-1  containing  PI3  kinase  complexes  catalyze  autophagosome 
generation  and  fusion  with  lysosomes.  The  Beclin-1  containing  complex with Atg14L, 
VPS34  and  VPS15  marks  membranes  at  which  the  phagophore  forms,  which  expands 
around its substrates with the help of the two ubiquitin-like molecules Atg8 and 12 and 
upon closure constitutes double-membrane surrounded autophagosomes. Their fusion with 
lysosomes is assisted by the UVRAG, VPS34 and VPS15 containing Beclin-1 complex. 
Recruitment of Rubicon into this complex blocks autophagosome fusion with lysosomes. 
 
3. Macroautophagy in Pathogen Sensing 
Pathogen sensing is the first step during the initiation of immune responses. Pathogen-associated 
molecular pattern (PAMP) receptors detect motifs in viruses, bacteria, fungi and parasites [28]. This 
recognition alarms the immune system by cytokine secretion and activation of antigen presenting cells. 
Different pattern recognition receptor (PRR) families monitor extracellular and intracellular space. 
RIG-I like (RLRs) and NOD like receptors (NLRs, including inflammasomes) detect cytosolic RNA 
and DNA, crystals or other danger molecules, respectively. In contrast, Toll-like (TLRs) and C-type 
lectin like receptors (CLRs) detect extracellular pathogen products. Interestingly, some TLRs signal 
from vesicular compartments and access to these endosomal TLRs (TLR3, 7, 8 and 9) can be regulated 
by vesicular transport. Along these lines it has been demonstrated that replication intermediates of 
Sendai and Vesicular Stomatitis virus require macroautophagy to be sensed by TLR7/8 [29]. Transport 
of these viral RNAs into TLR7/8 containing endosomes by autophagosomes was required for IFN 
production by plasmacytoid dendritic cells (DCs) in response to infection. Similarly, macroautophagy 
has been shown to facilitate B cell receptor ligand transport to TLR9 containing endosomes for B cell 
activation [30]. Thus, PAMP sensing by vesicular TLRs of antigen presenting cells seems to benefit 
from macroautophagic transport of ligands to endosomes. 
In contrast, cytosolic PRRs might be negatively regulated by macroautophagy. In the absence of 
Atg5, a component of the Atg8/LC3 E3-like ligase, dsRNA elicits increased IFN production via  
RIG-I  recognition  in  mouse  embryonic  fibroblasts  [31].  Deficiency  of  macroautophagy  leads  to Viruses 2011, 3                                       
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enhanced reactive oxygen species (ROS) production by dysfunctional mitochondria, which directly 
stimulates RLR activation [32]. ROS production does not only augment RLR, but also NLR signaling. 
Indeed Atg16L1 deficient macrophages produce elevated levels of inflammasome dependent IL-1 [33]. 
This elevated inflammasome activity is dependent on mitochondrial ROS, and inflammasomes and 
ROS  contribute  to  mitochondrial  DNA  release  into  the  cytosol,  which  augments  IL-1  production 
[34,35].  Thus,  PAMP  recognition  by  vesicular  TLRs  of  antigen  presenting  cells  is  supported  by 
macroautophagy, while the same process dampens cytosolic PAMP recognition in somatic cells. This 
could benefit the initiation of immune responses by focusing activation towards antigen presenting 
cells, like DCs and B cells. 
4. Contribution of Macroautophagy to Innate and Adaptive Immunity 
During such immune responses macroautophagy restricts intracellular pathogens and allows for 
antigen  presentation  to  the  adaptive  immune  system.  Indeed  during  the  engulfment  of  group  A 
Streptococci autophagosomes can reach ten-fold larger diameters (10 m) than usually observed for 
metabolic  autophagosomes  (0.5–1  m  in  diameter)  [36].  Macroautophagy  restricts  these  bacteria, 
which escape from endosomes to replicate in the cytosol. Interestingly, the formation of these large 
Streptococci containing autophagosomes requires Rab7, a GTPase that has previously been described 
to mediate autophagosome fusion to lysosomes [37]. In addition to bacteria, parasites like Toxoplasma 
gondii  seems  to  be  targeted  by  macroautophagy  [38,39].  Toxoplasma  conditions  phagosomes  to 
prevent  their  fusion  with  lysosomes,  which  allows  the  parasite  to  replicate  in  these  vesicular 
compartments. The protective phagosome membrane, however, can be stripped by immunity related 
GTPase M (IRGM), which then exposes Toxoplasma to macroautophagy, leading to degradation in 
lysosomes  [39].  Similar  mechanisms  might  be  at  work  during  the  restriction  of  Mycobacterium 
tuberculosis  growth  inhibition  by  macroautophagy  [40,41].  Finally,  neurotrophic  Sindbis  virus 
infection  is  also  compromised  by  macroautophagy  [42,43].  Enhancement  of  macroautophagy  by 
Atg6/Beclin-1 overexpression [42] compromises Sindbis virus replication, while deficiency of Atg5 in 
neurons increases immunopathology of Sindbis virus infection in the central nervous system of mice 
[43]. While the detailed mechanism of viral restriction is not known so far, it might involve direct 
degradation  of  viral  particles.  In  addition  to  simply  using  lysosomal  hydrolysis  for  pathogen 
destruction, autophagosomes also deliver substrates to lysosomes, from which antibacterial peptides 
can be generated. These include ubiquitin [44] and the ubiquitin-domain containing ribosomal protein 
Fau [45]. Thus, macroautophagy can restrict bacteria, parasites and viruses during immune responses. 
As a byproduct of this, pathogen degradation fragments are recycled for antigen presentation on 
MHC molecules to T cells. Especially, antigen processing for MHC class II presentation to CD4
+ 
helper T cells utilizes lysosomal hydrolysis. Accordingly, intracellular antigen processing of some 
viral and bacterial antigens utilizes macroautophagy [46–49]. In good agreement with these examples 
of antigen processing by macroautophagy, autophagosomes have been found to frequently fuse with 
MHC class II loading compartments [50], and enhanced autophagosome formation due to starvation 
changes the repertoire of MHC class II presented peptides to contain more frequently ligands, which 
are derived from cytosolic and nuclear proteins [51]. This alteration of the MHC class II presented 
ligandome by macroautophagy leads also to deficient positive and negative T cell selection in the Viruses 2011, 3                                       
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thymus  [52].  Furthermore,  even  though  mechanistically  not  very  well  understood  so  far,  Atg5 
deficiency in DCs compromises the development of CD4
+ T cell responses upon herpes simplex virus 
(HSV)  infection  of  mice  [53],  and  loss  of  an  HSV  encoded  macroautophagy  inhibitor  augments  
CD4
+ T cell responses during infection  [54]. These  studies suggest that degradation of pathogens  
via macroautophagy leads to MHC class II presentation of their fragments for stimulation of CD4
+ T 
cell responses. 
5. Inhibition of Autophagosome Generation by Viral Proteins Interacting with Beclin-1 
However, viruses counteract these beneficial functions of macroautophagy for immune responses. 
They  have  developed  strategies  to  both  target  autophagosome  generation  and  autophagosome 
maturation.  A  rich  source  of  inhibitors  of  autophagosome  generation  is  the  herpesvirus  family  
(Figure  2  and  Table  1)  [55].  In  fact,  all  three  herpesvirus  subfamilies  encode  inhibitors  of 
macroautophagy,  which  primarily  target  the  Atg14L  containing  Beclin-1  complex  of  VPS34  and 
VPS15. The -herpesvirus HSV-1 encodes the ICP34.5 protein, which interacts with Beclin-1 via a  
20  amino  acid  region  (aa  68-87)  and  thereby  compromises  autophagosome  generation  [56].  HSV 
encoding ICP34.5, in which this region has been deleted, demonstrates attenuated neurovirulence in 
mice. In correlation with this attenuated neurovirulence, autophagosome accumulation can be observed 
in mutant virus infected neurons, and loss of the double-strand RNA-dependent kinase PKR, which 
stimulates  macroautophagy  in  HSV  infected  cells,  eliminates  the  protective  function  of  elevated 
macroautophagy  against  mutant  HSV.  Without  ICP34.5,  HSV  particles  can  be  found  in 
autophagosomes  by  electron  microscopy  [57,58].  In  addition,  loss  of  ICP34.5  also  elevates  HSV 
specific  CD4
+  T  cell  responses  during  infection  [54].  Besides  HSV,  -herpesviruses  also  encode 
Beclin-1 interacting proteins. Kaposi sarcoma associated herpesvirus (KSHV) encodes a viral Bcl-2 
homologue with its open reading frame (orf) 16. This binds Atg6/Beclin-1 with higher affinity than 
cellular  Bcl-2  [59].  Binding  of  viral  Bcl-2  inhibits  macroautophagy  by  interrupting  Beclin-1 
incorporation  in  VPS34  complexes,  probably  via  anchoring  Beclin-1  at  endoplasmic  reticulum 
membranes [60]. Similarly, the viral Bcl-2 homologue M11 of the murine -herpesvirus 68 (MHV-68) 
interacts with Beclin-1 and inhibits autophagosome formation [61]. It binds with higher affinity to 
Beclin-1  than  cellular  Bcl-2  and  Bcl-xL.  Three  amino  acids  at  positions  85-87  are  required  for 
Beclin-1  binding  by  M11,  and  a  C-terminally,  but  not  N-terminally  truncated  molecule  can  still 
interact with Beclin-1 [62]. Interestingly, recombinant viruses lacking either the N-terminal 1 helix or 
with  mutated  amino  acids  85-87  no  longer  inhibited  macroautophagy  upon  infection,  and  loss  of 
macroautophagy inhibition compromised persistence of MHV-68 in vivo [62]. Thus, herpesviruses 
sequester Beclin-1 to inhibit autophagosome formation to enhance their neurovirulence and increase 
their persistence in vivo.  Viruses 2011, 3                                       
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Figure  2. Viral proteins block autophagosome generation and degradation via Beclin-1 
binding. KSHV orf16, MHV-68 M11 and HSV-1 ICP34.5 anchor Beclin-1 at membranes 
and block its incorporation into the PI3 kinase complex with VPS34, VPS15 and Atg14L, 
which catalyzes autophagosome generation. Furthermore influenza A virus M2 and HIV 
nef presumably stabilize through their Beclin-1 binding inhibitory PI3 kinase complexes 
that prevent fusion between autophagosomes and lysosomes. 
 
6. Immune Escape from Autophagosome Maturation via Targeting of Beclin-1 
In contrast to the DNA viruses of the herpesvirus family that inhibit autophagosome generation, 
RNA  viruses  seem  to  stabilize  autophagosomes  by  preventing  their  degradation.  Indeed,  both 
infections with the hepatitis C virus and poliovirus accumulate autophagosomes, and benefit for their 
replication from this macroautophagy regulation [63–66]. However, for these and most other viral 
infections, this autophagosome accumulation is mechanistically not well understood. However, in two 
instances,  influenza  and  human  immunodeficiency  virus  (HIV)  infection,  some  insights  into 
mechanisms of autophagosome accumulation have been gained, and both pathogens target Beclin-1, 
presumably  stabilizing  complexes  of  Beclin-1,  VPS34,  VPS15,  UVRAG  and  Rubicon  that  inhibit 
autophagosome maturation (Figure 2 and Table 1). Influenza A virus infection stabilizes autophagosomes, 
which fuse to large perinuclear vesicles and contain viral proteins, but not any lysosomal markers [67]. 
Matrix protein 2 (M2) of influenza A virus can induce this autophagosome accumulation, is localized 
to these accumulating autophagosomes, and M2 deficient virus does no longer establish this block of 
macroautophagy. Interestingly, the main function of M2, its proton channel activity that is required for 
viral core acidification during infection, does not seem to be involved in autophagosome stabilization. 
Instead full-length and a truncated M2 version (aa 1-60) are able to interact with Beclin-1. Inhibition of 
autophagosome  maturation  compromised  survival  of  influenza  A  virus  infected  cells,  thereby 
enhancing the pro-apoptotic effect of the viral protein PB-F1 by blocking the pro-survival pathway 
macroautophagy. Under certain infection conditions, this regulation of macroautophagy might also 
benefit viral replication [68]. Furthermore, consistent with inhibition of autophagosome maturation, 
influenza A virus antigens are not processed intracellularly for MHC class II presentation to CD4
+ T 
cells [69]. Instead, proteasomal degradation facilitates intracellular influenza antigen processing for 
MHC class II presentation. This suggests that proteasomal degradation takes over when macroautophagy Viruses 2011, 3                                       
 
 
1172 
is  blocked,  and  vice  versa  an  increase  in  macroautophagy  can  be  detected  in  cells  treated  with 
proteasomal  inhibitors  [66,70].  Interestingly,  autophagosome  generation  facilitates  antigen  transfer 
from  influenza  A  virus  infected  cells  to  neighboring  DCs  [71].  It  is  tempting  to  speculate  that 
exocytosis of viral protein carrying autophagosomes, which accumulate due to the M2 inducted block 
of their fusion with lysosomes, might contribute to this cross-presentation. Similar to influenza A 
virus,  HIV  blocks  autophagosome  maturation  in  infected  macrophages  [72].  HIV  gag  proteins 
accumulate in the stabilized autophagosomes and this autophagosome accumulation enhances viral 
replication in macrophages. The virus achieves this autophagosome accumulation via its nef protein, 
which co-localizes with autophagosomes and binds to Beclin-1 via its DD motif (aa 174-175) and this 
motif is required for autophagosome accumulation by nef. This fusion block is also established in DCs 
upon HIV infection, and prevents the formation of so-called immunoamphisomes [73]. These studies 
suggest  that  HIV  and  influenza  A  virus  block  autophagosome  maturation  by  encoding  Beclin-1 
interacting proteins.  
Table 1. Viral proteins that interact with Atg6/Beclin-1. 
Virus  Protein  Function  Reference 
HSV-1  ICP34.5  blocks autophagosome generation  [54] 
KSHV  orf16  blocks autophagosome generation  [58] 
MHV-68  M11  blocks autophagosome generation  [59,60] 
HIV  nef  blocks autophagosome maturation  [70] 
Influenza A  M2  blocks autophagosome maturation  [65] 
7. Conclusions 
Macroautophagy, a pathway that has been originally appreciated for its pro-survival function in 
nutrient  recycling  during  starvation,  has  in  recent  years  been  recognized  for  its  functions  during 
immune responses. Both pathogen sensing by innate and adaptive immune compartment, as well as 
pathogen destruction through this pathway are supported by macroautophagy. Accordingly, successful 
viral pathogens have learned to interfere with this pathway for their own benefit. While herpesviruses 
inhibit  autophagosome  generation,  many  RNA  viruses,  including  influenza  virus  and  HIV,  block 
autophagosome maturation and degradation, but seem to benefit from stabilization of these vesicles. 
Interestingly, both inhibition of autophagosome generation and degradation seems to be often achieved 
through  viral  protein  binding  to  Beclin-1,  probably  regulating  complexes  of  this  essential 
macroautophagy protein that are either involved in phagophore generation or autophagosome fusion 
with lysosomes. How this is achieved by the different viral proteins remains to be seen. However, 
these viral modulators of macroautophagy already now give us tools to experimentally regulate this 
catabolic  pathway,  and  interference  with  their  function  might  hopefully  suggest  some  therapeutic 
interventions against the encoding viruses in the future. 
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